Press & News
The next generation biopharmaceuticals
Press releases 2014
2014-11-27
Older press releases
2014-11-20
2014-08-22
2014-05-20
Affibodys latest Press releases
2018-03-21
Affibody Announces First Psoriasis Patients Dosed in a Phase II Clinical Trial of ABY-035
Affibody in short
Affibody is a Swedish biotech company focused on developing next generation biopharmaceuticals based on its unique proprietary technology platforms: Affibody® molecules and Albumod™.
Upcoming reports Financial calendar
- Year-end report (February 24, 2017)